Tandem OnabotulinumtoxinA Galcanezumab Emerging Therapeutic Headache Elimination Research Study
Clinical trial NCT05492695 · TERMINATED
Trial details
- NCT number
- NCT05492695
- Sponsor
- Diamond Headache Clinic
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2023-09-28
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.